Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-02-09 @ 10:44 PM
Study NCT ID:
NCT04030195
Status:
COMPLETED
Last Update Posted:
2023-01-31
First Post:
2019-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL
Sponsor:
Precision BioSciences, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Hodgkin's Lymphoma, Relapsed | View |
| None | Chronic Lymphoid Leukemia in Relapse | View |
| None | Non-Hodgkin's Lymphoma Refractory | View |
| None | Chronic Lymphocytic Leukemia | View |
| None | Lymphoma, Non-Hodgkin | View |
| None | Leukemia, Lymphocytic, Chronic | View |
| None | B-cell Chronic Lymphocytic Leukemia | View |
| None | B-cell Non Hodgkin Lymphoma | View |
| None | Small Lymphocytic Lymphoma | View |
Keywords: